Evidence map›Paper›PMID 29920482›Full record

ReviewOncology2018

Tobacco Cessation in Oncology Care.

Emily G Kaiser, Judith J Prochaska, Matthew S Kendra

Abstract readReview
In one paragraph

Review in Oncology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Overcoming "Cessation Stasis": The Need to Address Inertia.Journal of the National Cancer Institute · 2022
    Article
  7. Article
  8. Review
  9. Smoking cessation knowledge and perceptions of cancer care providers at six Latin American cancer institutions.Revista panamericana de salud publica = Pan American journal of public health · 2022
    Article
  10. Smoking Cessation in Cancer Survivors.Korean journal of family medicine · 2021
    Article
  11. Implementation of tobacco cessation services at a comprehensive cancer center: a qualitative study of oncology providers' perceptions and practices.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Emily G KaiserPGSP-Stanford Psy.D. Consortium, Palo Alto, California, USA.
Judith J ProchaskaDepartment of Medicine, Stanford University School of Medicine, Stanford, California, USA.
Matthew S KendraDepartment of Psychiatry and Behavioral Sciences, Stanford University School of Medicine, Stanford, California, USA.

Funding

Social Media Technology for Treating Tobacco AddictionR01CA204356 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI PECHMANN, CORNELIA, PROCHASKA, JUDITH J. · 2016 to 2020
$2.6M
NCI NIH HHS R01 CA204356
6 · The paper itself

Abstract

Globally, tobacco use is a major modifiable risk factor and leading cause of many forms of cancer and cancer death. Tobacco use contributes to poorer prognosis in cancer care. This article reviews the current state of tobacco cessation treatment in oncology. Effective behavioral and pharmacological treatments exist for tobacco cessation, but are not being widely used in oncology treatment settings. Comprehensive tobacco treatment increases success with quitting smoking and can improve oncological and overall health outcomes. This article describes the components of a model treatment program, which includes automatic referrals for all current tobacco users and recent quitters, motivational interviewing during initial and follow-up contacts, combined behavioral and pharmacological interventions for cessation, and systematic follow-up phone calls for relapse prevention.

Indexed as

HumansMedical OncologyNeoplasmsNicotianaRisk FactorsSmoking CessationTobacco Use CessationCancerCessationNicotineOncologyPreventionSmokingTobaccoTreatment

Identifiers

PMID29920482
PMCPMC7020252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.